All data are based on the daily closing price as of December 5, 2025
h
Humedix
200670.KQ
29.87 USD
-0.18
-0.60%
Overview
Last close
29.87 usd
Market cap
309.45M usd
52 week high
54.97 usd
52 week low
18.18 usd
Target price
41.4 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
4.1025
Price/Book Value
1.7168
Enterprise Value
225.42M usd
EV/Revenue
2.0565
EV/EBITDA
5.7225
Key financials
Revenue TTM
75.33M usd
Gross Profit TTM
29.91M usd
EBITDA TTM
19.18M usd
Earnings per Share
N/A usd
Dividend
0.71 usd
Total assets
206.06M usd
Net debt
N/A usd
About
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.